The landscape of modern molecular research is constantly evolving, with researchers identifying unique compounds that offer rem Thedepsipeptideproject is a joint and collaborative effort between many groups within the Center for Chemical Evolution (CCE).Read more arkable structural diversity. Among these, the depsipeptide drug class has emerged as a by S Sivanathan·2014·Cited by 121—This review gives an overview of natural depsipeptides with ring-sizes between 12 and 30 atoms and composed exclusively of α-amino acids and at least one α- Read more significant area of interest. These compounds are essentially polypeptides in which one or more amino acid is replaced by a hydroxy acid, resulting in the formation of at least one ester bond within the backbone. This distinct chemical architecture sets them apart from standard proteins and peptides.
Understandin Effect of depsipeptide in combination with chemotherapeutic agentson cytotoxicity in drug-resistant CHLA-172 neuroblastoma cells. In drug combination Read more g the Nature of Depsipeptides
At their core, a depsipeptide is a type of nonribosomal peptide that is cyclized through an ester bond and often contains nonprotein amino acids. These molecules are made naturally by some bacteria, fungi, and other organisms, though many can now be synthesized in the laboratory. Because they are nonribosomal peptides that typically contain up to 20 amino acids, they often form complex cyclic scaffolds with diverse side chains.
From a structural perspective, a depsipeptide is a cyclic peptide where one or more of its amide groups are substituted by the analogous ester. This modification is not merely cosmetic; it fundamentally alters the molecule's interaction with biological targe Depsipeptide Synthesis ts. For instance, the formula and molecular weight of kahalalide F, a well-known member of this class, illustrate the complexity that researchers must account for when investigating these comp Depsipeptide - an overview | ScienceDirect Topics ounds.
Key Examples and Research Milestones
The scientific community has identified several notable compounds that fall under this classification, each c by H Nan·2025·Cited by 2—Lagunamide D is a structurally distinct 26-membered cytotoxic cyclicdepsipeptide, originally isolated from a marine cyanobacterium. ontributing to our understanding of molecular biology:
* Romidepsin (FK228): Perhaps the most recognized example, this is a histone deacetylase inhibitor molecule that has been widely studied. It is derived from *Chromobacterium violaceum* and functions as a type of prodrug that is activated through reduction upon cellular uptake.
* Dolastatin 10: This compound is frequently cited in studies regarding microtubule assembly and its interaction with tumor cell dynamics.
* YM-280193: This is a cyclic depsipeptide recognized for its specific inhibitory effects on platelet aggregation.
* Wajeepeptin (1): A more recent discovery, this novel cyclic depsipeptide was isolated from marine environments and contains unique $\beta$-amino acid residues.
The Role of Depsipeptides in Modern Discovery
The interest in these compounds is driv The Krishnamurthy Lab en by their biological activity. Cyclodepsipeptides exhibit a broad spectrum of biological activities, including antitumor, antibacterial, antiviral, antifungal, anti-inflammatory, and anti-clotting properties. As an emerging new modality in drug discovery research, these molecules provide a rich source of lead compounds.
When we consider the "depsipeptide" as a foundational scaffold, its utility becomes Effect of depsipeptide in combination with chemotherapeutic agentson cytotoxicity in drug-resistant CHLA-172 neuroblastoma cells. In drug combination Read more clear. Many researchers are currently investigating the effect of depsipeptide in combination with chemotherapeutic agents to modulate gene expression via histone deacetylase inhibition. By controlling the acetylation of histones, these molecules can influence cellular pathways in highly specific ways.
Future Directions
The potential for these compounds extends beyond traditional laboratory settings. Because they have significant therapeutic applications in oncology and antimicrobial therapy, they are often evaluated in advanced research trials. For example, some variants are used in refractory cancer therapy, usually in combination with other established protocols to optimize outcomes.
As we continue to map the chemical space of these molecules, the focus remains on the synthesis and optimization of cyclic structures. Whether it is the study of *Chromobacterium violaceum* derivatives or the total synthesis of complex marine-derived molecules, the study of the depsipeptide drug remains a cornerstone of contemporary chemical biology. By understanding how these nonribosomal peptides interact with their targets, we gain deeper insights into the vast, untapped potential of natural product chemistry.